Macomics
Pre-clinicalDeveloping new breakthrough approaches to targeting macrophage activity to change the course of disease.
Founded
2019
Focus
AntibodiesBiologics
About
Developing new breakthrough approaches to targeting macrophage activity to change the course of disease.
Funding History
2Total raised: $23.8M
Series A$20MNovo HoldingsOct 15, 2022
Seed$3.8MEpidarex CapitalSep 15, 2020
Company Info
TypePrivate
Founded2019
LocationEdinburgh, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile